About Amneal
Amneal is a company based in Bridgewater (United States) founded in 2002. The company has 8,300 employees as of December 31, 2024. Amneal has completed 7 acquisitions, including AvKARE, Epsilon Pharmaceuticals and Gemini Laboratories. Amneal offers products and services including Generic Products, Specialty Products, and Biosciences Products.
- Headquarter Bridgewater, United States
- Employees 8300 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Amneal Pharmaceuticals, Inc.
-
Annual Revenue
$2.79 B (USD)16.73as on Dec 31, 2024
-
Net Profit
-$116.89 M (USD)-39.16as on Dec 31, 2024
-
EBITDA
$589.48 M (USD)19.71as on Dec 31, 2024
-
Latest Funding Round
$19.2 M (USD), Post-IPO
Nov 16, 2018
-
Investors
Northern Trust
& 2 more
-
Employee Count
8300
as on Dec 31, 2024
-
Investments & Acquisitions
AvKARE
& 6 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Amneal
Amneal is a publicly listed company on the NASDAQ with ticker symbol AMRX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Amneal
Amneal offers a comprehensive portfolio of products and services, including Generic Products, Specialty Products, and Biosciences Products.
Essential generic medicines for treating various common health conditions
Innovative drugs for specific diseases like Parkinson's and oncology
Advanced biosimilars for institutional and patient use worldwide
People of Amneal
Unlock access to complete
Unlock access to complete
Human Resources and Administration
35 people
Leadership Team
24 people
Finance and Accounting
24 people
Software Development Team
21 people
Legal and Compliance
9 people
Product Management Team
3 people
Senior Team
3 people
Sr. Team
3 people
Unlock access to complete
Funding Insights of Amneal
Investors in Amneal
Amneal has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Northern Trust, GE Capital and Tarsadia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and private equity are directed toward multiple sectors.
|
Locked | Locked | Locked | |
|
Financial and wealth management services are provided worldwide.
|
Locked | Locked | Locked | |
|
Commercial aircraft and equipment leasing and lending services are provided.
|
Locked | Locked | Locked |
Investor details for Amneal
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Amneal
Amneal has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include AvKARE, Epsilon Pharmaceuticals and Gemini Laboratories.
Investment portfolio details for Amneal
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutic solutions for rare diseases are developed.
|
Locked | Locked | 2020 | Locked | |
|
Therapeutic products are developed and manufactured by Puniska.
|
Locked | Locked | 2017 | Locked | |
|
Science-based nutrition products are developed for infants, children, and adults.
|
Locked | Locked | 2013 | Locked |
Complete acquisition details for Amneal
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Amneal
Detailed financials for Amneal
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Amneal Comparisons
Peer comparison for Amneal
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Amneal
Detailed competitors of Amneal
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Amneal
Complete news archive for Amneal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amneal
Amneal was founded in 2002 and raised its 1st funding round 3 years after it was founded.
Amneal is headquartered in Bridgewater, United States. It is registered at Bridgewater, New Jersey, United States.
As of Dec 31, 2024, the latest employee count at Amneal is 8,300.
Annual revenue of Amneal is $2.79B as on Dec 31, 2024.
Amneal Pharmaceuticals is a fully-integrated pharmaceutical company focused on the development, manufacture, and distribution of generic and specialty drug products. The company has an extensive portfolio of approximately 250 generic medicines and is expanding its portfolio to include complex dosage forms including biosimilars in a broad range of therapeutic areas. The company also markets a portfolio of branded pharmaceutical products through its specialty segment focused principally on the central nervous system and endocrine disorders.
Amneal offers Generic Products, Specialty Products, and Biosciences Products.
Yes, Amneal is publicly traded on NASDAQ under the ticker symbol AMRX.
Amneal has made 7 acquisitions, including AvKARE, Epsilon Pharmaceuticals, and Gemini Laboratories.
Amneal has 3 investors. Key investors include Northern Trust, GE Capital, and Tarsadia.
The ticker symbol of Amneal is AMRX on NASDAQ.